APOBEC3B and nonpapillary renal cell carcinoma: The outcomes indicated that APOBEC3B (HR: 1.09), APOBEC3D (HR: 1.10), and APOBEC3F (HR: 0.84) exhibited independent prognostic value for ccRCC (Table 2).